23andMe enters infertility space with Celmatix partnership
23andMe and Celmatix are combining forces to understand the genomic underpinnings of infertility.
23andMe and Celmatix are combining forces to understand the genomic underpinnings of infertility.
New York startup Celmatix just raised $5.5 million for its predictive software that determines a woman's likelihood of infertility based on her genomics.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.